The acquisition of Your Research by Almac Clinical Technologies brings several specific features and potential impacts to clinical trials

Almac Clinical Technologies has embarked on an exciting new chapter with the acquisition of Your Research, a Netherlands-based eClinical company. This strategic move aims to enhance Almac’s suite of clinical trial solutions by integrating Your Research’s advanced technology with Almac’s industry-leading IXRS®3 software.

The combined solutions will offer a comprehensive range of eClinical features and services, including electronic Clinical Outcome Assessments (eCOA), eConsent, Visit Management, and participant retention. These advancements are designed to streamline workflows, improve data management, and ensure protocol compliance, making it easier for participants, sites, and sponsors to engage with studies and analyse data in real-time.

The phased rollout of these new solutions is expected to start mid-2025, with broader expansion anticipated later in the year. This acquisition reflects Almac’s proactive approach to addressing key challenges in the clinical trial process and enhancing the overall experience for all stakeholders involved.